What is the Market's View on Inmode Ltd (INMD) Stock's Price and Volume Trends Friday?

Overall market sentiment has been high on Inmode Ltd (INMD) stock lately. INMD receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Inmode Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on INMD!

See Full INMD Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With INMD Stock Today?

Inmode Ltd (INMD) stock has risen 0.68% while the S&P 500 is down -0.63% as of 10:00 AM on Friday, Sep 17. INMD has gained $0.96 from the previous closing price of $140.63 on volume of 196,509 shares. Over the past year the S&P 500 is higher by 31.31% while INMD has gained 289.95%. INMD earned $2.99 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 47.62. To see InvestorsObserver's Sentiment Score for Inmode Ltd click here.

More About Inmode Ltd

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States. Click Here to get the full Stock Report for Inmode Ltd stock.